Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility

Genomics
M AngristA Chakravarti

Abstract

Congenital aganglionic megacolon, commonly known as Hirschsprung disease (HSCR), is the most frequent cause of congenital bowel obstruction. Germline mutations in the RET receptor tyrosine kinase have been shown to cause HSCR. Knockout mice for RET and for its ligand, glial cell line-derived neurotrophic factor (GDNF), exhibit both complete intestinal aganglionosis and renal defects. Recently, GDNF and GFRA1 (GDNF family receptor, also known as GDNFR-alpha), its GPI-linked coreceptor, were demonstrated to be components of a functional ligand for RET. Moreover, GDNF has been implicated in rare cases of HSCR. We have mapped GFRA1 to human chromosome 10q25, isolated human and mouse genomic clones, determined the gene's intron-exon boundaries, isolated a highly polymorphic microsatellite marker adjacent to exon 7, and scanned for GFRA1 mutations in a large panel of HSCR patients. No evidence of linkage was detected in HSCR kindreds, and no sequence variants were found to be in significant excess in patients. These data suggest that GFRA1'S role in enteric neurogenesis in humans remains to be elucidated and that RET signaling in the gut may take place via alternate pathways, such as the recently described GDNF-related molecule neurt...Continue Reading

References

Oct 1, 1985·Teratology·D Spouge, P A Baird
May 1, 1995·Human Molecular Genetics·M AngristA Chakravarti
Jun 27, 1996·Nature·P DurbecM Saarma
Jul 4, 1996·Nature·M W MooreA Rosenthal
Jul 4, 1996·Nature·J J TreanorA Rosenthal
Oct 1, 1996·Neuron·R M Lindsay, G D Yancopoulos
Jan 1, 1997·Trends in Genetics : TIG·K Robertson, I Mason
Jan 1, 1997·Pediatric Surgery International·G Martucciello
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·M SanicolaR L Cate
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·D J CreedonE M Johnson

❮ Previous
Next ❯

Citations

Nov 10, 2000·Journal of Medical Genetics·J R Hansford, L M Mulligan
Nov 6, 2001·Journal of Medical Genetics·J Amiel, S Lyonnet
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·S BolkA Chakravarti
Jul 17, 1999·Critical Reviews in Clinical Laboratory Sciences·R P Kapur
Apr 30, 2002·International Journal of Cancer. Journal International Du Cancer·Laura GilJosé M Rojas
Sep 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naoya KatoMasao Omata
Mar 26, 2003·Journal of Cellular Physiology·Luisella AlbertiMarco A Pierotti
Feb 3, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Xingguang LuoJoel Gelernter
Jun 22, 2000·Molecular and Cellular Neurosciences·M LindahlM S Airaksinen
Jul 2, 2009·BMC Bioinformatics·Tsutomu MatsunagaMasaaki Muramatsu
Apr 16, 2002·Nature Genetics·Stacey B GabrielAravinda Chakravarti
Apr 26, 2002·European Journal of Human Genetics : EJHG·Silvia BorghiniIsabella Ceccherini
Jan 23, 1999·Nature Genetics·A Chakravarti
Oct 13, 2006·Current Opinion in Gastroenterology·William M Belknap
Jun 18, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Vincent Chi Hang LuiPaul Kwong Hang Tam
Oct 5, 2001·Trends in Genetics : TIG·S ManiéM Billaud
Dec 2, 1999·Gastroenterology·C GiaroniG Frigo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.